Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis

ClinicalTrials.gov ID: NCT02065557

Public ClinicalTrials.gov record NCT02065557. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 6:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to demonstrate the efficacy and safety, and to assess the pharmacokinetics of adalimumab administered subcutaneously (SC) in pediatric subjects with moderate to severe ulcerative colitis (UC).

Study identification

NCT ID
NCT02065557
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
101 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
4 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 12, 2014
Primary completion
Feb 6, 2020
Completion
Feb 6, 2020
Last update posted
Oct 4, 2020

2014 – 2020

United States locations

U.S. sites
16
U.S. states
10
U.S. cities
14
Facility City State ZIP Site status
Childrens Hospital LA /ID# 147452 Los Angeles California 90027
Univ California, San Francisco /ID# 120901 San Francisco California 94143-2204
Arnold Palmer Hosp Children /ID# 120898 Orlando Florida 32806
Emory University Hospital /ID# 121858 Atlanta Georgia 30322
Children's Ctr Digestive, US /ID# 121855 Atlanta Georgia 30342
University of Chicago /ID# 120904 Chicago Illinois 60637-1443
Loyola University Medical Ctr /ID# 120900 Maywood Illinois 60153
Indiana University /ID# 120908 Indianapolis Indiana 46202
Massachusetts General Hospital /ID# 124551 Boston Massachusetts 02114
Boston Childrens Hospital /ID# 147714 Boston Massachusetts 02115
Mayo Clinic - Rochester /ID# 121056 Rochester Minnesota 55905-0001
Minnesota Gastroenterology P.A /ID# 120895 Saint Paul Minnesota 55114
Goryeb Chidlren's Hospital /ID# 121860 Morristown New Jersey 07960
North Shore University Hospital /ID# 120905 New Hyde Park New York 11040
Univ Rochester Med Ctr /ID# 127776 Rochester New York 14642
Multicare Institute for Research and Innovation /ID# 147716 Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02065557, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 4, 2020 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02065557 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →